目的: 分析集中带量采购政策对人工关节置换术手术人次、次均总费用、次均患者负担费用、次均医保报销比例等的影响,评价政策实施效果。方法: 基于安阳市29家二级以上医疗机构人工关节置换术费用数据,采用Excel对比分析集采前后人工关节置换效果及费用数据变化情况等。结果: 集采后,人工髋关节、人工膝关节置换术手术患者数量增幅分别为50%、79.41%,次均总费用降幅分别为42.66%、40.85%,次均患者负担费用降幅分别为59.99%、46.23%,次均医保实际报销比例增幅分别为16.76%、4.16%。结论: 国家集中带量采购政策在降低患者医疗费用方面效果显著,大大减轻了患者的医疗负担,应积极发挥公立医院内部管理作用,促进政策可持续发展。
Abstract
Objective: The paper analyzes the impact of the centralized procurement policy on the number of patients undergoing artificial joint replacement surgery, the total cost per time, the cost of patients per time, and the proportion of medical insurance reimbursement per time, and evaluates the implementation effect of the policy. Methods: Based on the cost data of artificial joint replacement in 29 hospitals above Level II in Anyang City, the paper applies Excel to compare and analyze the effect of artificial joint replacement and the change of cost data before and after centralized purchase. Results: After the centralized procurement policy, the number of patients with artificial hip and knee replacement increased by 50% and 79.41%, respectively, the patient cost decreased by 59.99% and 46.23%, respectively, and the actual reimbursement ratio of both cases increased by 16.76% and 4.16%, respectively. Conclusion: The national centralized procurement policy has a remarkable effect in reducing the medical cost of patients and greatly reduces the medical burden of patients. Public hospitals should play an active role in internal management and promote the sustainable development of the policy.
关键词
国家集中带量采购 /
人工关节 /
次均费用
Key words
national centralized procurement /
artificial joint /
average cost per time
{{custom_sec.title}}
{{custom_sec.title}}
{{custom_sec.content}}
参考文献
[1] 于继洋,孙旭东,祝勇刚.人工关节置换术治疗老年髋臼骨折疗效及对患者血清炎性指标、骨代谢水平的影响[J].陕西医学杂志. 2022,51(04):419-423.
[2] 沈惠良. 深度老龄化社会进程中骨科医生面临的挑战——重视骨质疏松性骨折的治疗[J].北京医学. 2015,37(11):1020-1021.
[3] 边焱焱,程开源,常晓,等.2011至2019年中国人工髋膝关节置换手术量的初步统计与分析[J].中华骨科杂志,2020,40(21):1453-1460.
[4] BUCKWALTER, HECKMAN JD, PETRIE DP,等.北美人口老龄化问题:骨科界面临的新挑战[J].中国骨质疏松杂志. 2005,(03):399-408.
[5] 宁艳阳,人工关节带量采购“为用而采”[J].中国卫生,2021(11):54-57.
[6] 冷楠楠,邱英鹏,赵羽西,等.冠脉支架集中带量采购对医疗服务供给的潜在影响分析[J].卫生经济研究. 2022,39(05):1-3.
[7] 张健. 人工关节终于降价,集采带来五大利好[J].家庭医药.就医选药. 2021,(12):8-9.
[8] 洪志斌,李跃平,庄云龙,等.医用耗材集采政策实施效果评估——以厦门市某三级专科医院为例[J].中国医疗保险,2022(10):40-42.
[9] 孙鹏,辛禹,祁鹏,等.基于德尔菲法的医用耗材集采平台建设运行评价指标体系构建[J].中国医疗保险,2022(05):102-106.